March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
A Viable Mouse PDGFR-Beta Mutant Exhibits CNS-restricted Pericyte Deficiency And Blood Brain Barrier Defects
Author Affiliations & Notes
  • Shalini Jadeja
    MRC Human Genetics Unit, MRC IGMM at the University of Edinburgh, Edinburgh, United Kingdom
  • Margaret Keighren
    MRC Human Genetics Unit, MRC IGMM at the University of Edinburgh, Edinburgh, United Kingdom
  • Fay Cooper
    MRC Human Genetics Unit, MRC IGMM at the University of Edinburgh, Edinburgh, United Kingdom
  • Ian J. Jackson
    MRC Human Genetics Unit, MRC IGMM at the University of Edinburgh, Edinburgh, United Kingdom
  • Footnotes
    Commercial Relationships  Shalini Jadeja, None; Margaret Keighren, None; Fay Cooper, None; Ian J. Jackson, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2558. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shalini Jadeja, Margaret Keighren, Fay Cooper, Ian J. Jackson; A Viable Mouse PDGFR-Beta Mutant Exhibits CNS-restricted Pericyte Deficiency And Blood Brain Barrier Defects. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2558.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To characterize the mouse mutant Pedv/128, a partial loss of function of PdgfrB, as a possible model for Diabetic Retinopathy and as a tool for investigating the role of pericytes in maintaining a normal retinal vasculature.

Methods: : The mutant line Pedv/128 was identified during a recessive ENU mutagenesis screen at MRC Harwell, with blood in the eyes and was named redeye. Haplotype mapping followed by exome sequencing identified the gene mutated. Subsequently, detailed histological analysis on eye sections and immunohistochemistry on wholemount retinas were carried out to determine the effect of the mutation on the retinal vasculature. Vascular permeability assays were also performed to determine the extent of the vessel leakage.

Results: : A donor splice site mutation was identified in Pdgfrb which caused partial loss of normal splicing resulting in a frameshift and premature termination. Consequently there is a substantial reduction in expression of the normal Pdgfrb transcript. PDGF is an important regulator of embryological development, cell proliferation, migration and survival. PDGFB/PDGFRB signalling is required for pericyte recruitment to developing blood vessels in order to confer vessel stability and more recently has been implicated in the formation of the Blood Brain Barrier (BBB). We find that that the redeye strain exhibits vascular leakage due to a defect in pericyte recruitment, that is confined to the central nervous system (CNS). Consequently there is defective vessel patterning and vessel tortuousity, reduced basement membrane deposition as well as changes in the expression of BBB markers.

Conclusions: : Loss of function mutants of Pdgfrb are usually embryonic lethal due to severe haemorrhaging. Unusually, the redeye mutant mice are viable, with only the CNS vasculature affected. They are therefore a better model for diseases involving pericyte deficiencies such as Diabetic Retinopathy than those currently being used. In addition, the defect in BBB development makes them a useful tool for dissecting the role of pericytes in BBB formation and vascular development.

Keywords: development • pathobiology • diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×